The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease
- First Posted Date
- 2010-01-22
- Last Posted Date
- 2012-12-24
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 99
- Registration Number
- NCT01054976
A Study for Dacogen Treatment in Patients With Myelodysplastic Syndrome
- First Posted Date
- 2010-01-01
- Last Posted Date
- 2013-07-29
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 103
- Registration Number
- NCT01041846
A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy
Completed
- Conditions
- SeizuresConvulsionsEpilepsyOsteopeniaOsteoporosis
- Interventions
- First Posted Date
- 2009-12-11
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 140
- Registration Number
- NCT01030094
A Retreatment Study With Bortezomib for Multiple Myeloma
- First Posted Date
- 2009-12-11
- Last Posted Date
- 2013-03-08
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 56
- Registration Number
- NCT01030302
Observational Study of the Effects Intravenous Bortezomib Has on Osteoblast (Cell That is Responsible for Bone Formation) Activity in Multiple Myeloma Patients.
- First Posted Date
- 2009-12-04
- Last Posted Date
- 2014-04-28
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 104
- Registration Number
- NCT01026701
The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants
- First Posted Date
- 2009-11-30
- Last Posted Date
- 2013-08-12
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 203
- Registration Number
- NCT01021683
Quality of Life in Multiple Myeloma Patients Treated With Bortezomib
- First Posted Date
- 2009-11-30
- Last Posted Date
- 2014-12-23
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 140
- Registration Number
- NCT01021592
Practice and Patient Compliance on the PPI (Proton Pump Inhibitors) Treatment of Gastroesophageal Reflux in South Korea
- First Posted Date
- 2009-11-23
- Last Posted Date
- 2014-04-28
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 1197
- Registration Number
- NCT01018160
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
Phase 4
Completed
- Conditions
- Attention Deficit Disorder With Hyperactivity
- Interventions
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2014-03-14
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 142
- Registration Number
- NCT01012622
An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis
- First Posted Date
- 2009-11-06
- Last Posted Date
- 2013-08-13
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 217
- Registration Number
- NCT01008696
© Copyright 2025. All Rights Reserved by MedPath